Insider · CIK 0001920553

Reich Kristian

Reports to the SEC for 1 company · ZUG

sec.gov

Transactions

Companies

Filings

CIK

0001920553

Forms 4 and 5

Insider transactions

47 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-27	MLTXMoonLake ImmunotherapeuticsS Sale	Chief Scientific Officer	SSale	−1,100 sh	$20.00	−$22K	2,711,198
2026-07-22	MLTXMoonLake ImmunotherapeuticsS Sale	Chief Scientific Officer	SSale	−2,448 sh	$20.00	−$49K	2,712,298
2026-07-21	MLTXMoonLake ImmunotherapeuticsS Sale	Chief Scientific Officer	SSale	−50K sh	$20.02	−$1M	2,714,746
2026-07-20	MLTXMoonLake ImmunotherapeuticsS Sale	Chief Scientific Officer	SSale	−43.7K sh	$20.09	−$878K	2,764,746
2026-07-15	MLTXMoonLake ImmunotherapeuticsS Sale	Chief Scientific Officer	SSale	−16.1K sh	$20.01	−$322K	2,808,446
2026-06-17	MLTXMoonLake ImmunotherapeuticsS Sale	Chief Scientific Officer	SSale	−50K sh	$19.43	−$972K	2,824,551
2026-06-16	MLTXMoonLake ImmunotherapeuticsS Sale	Chief Scientific Officer	SSale	−50K sh	$18.70	−$935K	2,874,551
2026-06-15	MLTXMoonLake ImmunotherapeuticsS Sale	Chief Scientific Officer	SSale	−50K sh	$18.89	−$945K	2,924,551
2026-01-07	MLTXMoonLake Immunotherapeutics · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+520K sh	—	—	520,342
2025-12-19	MLTXMoonLake ImmunotherapeuticsC Conversion	Chief Scientific Officer	CConversion	+35.4K sh	—	—	35,389
2025-12-19	MLTXMoonLake ImmunotherapeuticsD Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−35.4K sh	—	—	0
2025-12-19	MLTXMoonLake Immunotherapeutics · Common shares, par value CHF 0.10 per share, of MoonLake AGC Conversion	Chief Scientific Officer	CConversion	−1,052 sh	—	—	0
2025-12-09	MLTXMoonLake ImmunotherapeuticsS Sale	Chief Scientific Officer	SSale	−72.9K sh	$14.43	−$1.05M	0
2025-12-08	MLTXMoonLake ImmunotherapeuticsS Sale	Chief Scientific Officer	SSale	−130K sh	$15.08	−$1.96M	72,908
2025-09-02	MLTXMoonLake ImmunotherapeuticsC Conversion	Chief Scientific Officer	CConversion	+49K sh	—	—	202,908
2025-09-02	MLTXMoonLake ImmunotherapeuticsD Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−49K sh	—	—	35,389
2025-02-27	MLTXMoonLake Immunotherapeutics · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+139K sh	—	—	139,273
2025-01-20	MLTXMoonLake Immunotherapeutics · Common shares, par value CHF 0.10 per share, of MoonLake AGC Conversion	Chief Scientific Officer	CConversion	−1,456 sh	—	—	1,052
2025-01-20	MLTXMoonLake ImmunotherapeuticsC Conversion	Chief Scientific Officer	CConversion	+112K sh	—	—	153,930
2025-01-20	MLTXMoonLake ImmunotherapeuticsD Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−112K sh	—	—	84,367
2025-01-20	MLTXMoonLake Immunotherapeutics · Common shares, par value CHF 0.10 per share, of MoonLake AGC Conversion	Chief Scientific Officer	CConversion	−3,328 sh	—	—	2,508
2024-02-28	MLTXMoonLake ImmunotherapeuticsS Sale	Chief Scientific Officer	SSale	−31.9K sh	$55.00	−$1.76M	2,925,573
2024-02-28	MLTXMoonLake ImmunotherapeuticsS Sale	Chief Scientific Officer	SSale	−28.1K sh	$55.00	−$1.54M	41,981
2024-02-27	MLTXMoonLake ImmunotherapeuticsS Sale	Chief Scientific Officer	SSale	−29.5K sh	$55.00	−$1.62M	2,957,483
2024-02-27	MLTXMoonLake ImmunotherapeuticsS Sale	Chief Scientific Officer	SSale	−29.4K sh	$55.00	−$1.62M	70,071
2024-02-21	MLTXMoonLake ImmunotherapeuticsS Sale	Chief Scientific Officer	SSale	−509 sh	$55.31	−$28.2K	2,986,974
2024-02-21	MLTXMoonLake ImmunotherapeuticsS Sale	Chief Scientific Officer	SSale	−569 sh	$55.30	−$31.5K	99,502
2024-02-20	MLTXMoonLake ImmunotherapeuticsS Sale	Chief Scientific Officer	SSale	−10K sh	$57.45	−$575K	2,987,483
2024-02-20	MLTXMoonLake ImmunotherapeuticsS Sale	Chief Scientific Officer	SSale	−10K sh	$57.43	−$574K	100,071
2024-02-16	MLTXMoonLake ImmunotherapeuticsS Sale	Chief Scientific Officer	SSale	−10K sh	$60.15	−$602K	2,997,483
2024-02-16	MLTXMoonLake ImmunotherapeuticsS Sale	Chief Scientific Officer	SSale	−10K sh	$60.15	−$602K	110,071
2024-02-15	MLTXMoonLake ImmunotherapeuticsS Sale	Chief Scientific Officer	SSale	−10K sh	$60.17	−$602K	3,007,483
2024-02-15	MLTXMoonLake ImmunotherapeuticsS Sale	Chief Scientific Officer	SSale	−10K sh	$60.16	−$602K	120,071
2024-02-14	MLTXMoonLake ImmunotherapeuticsS Sale	Chief Scientific Officer	SSale	−10K sh	$62.42	−$624K	3,017,483
2024-02-14	MLTXMoonLake ImmunotherapeuticsS Sale	Chief Scientific Officer	SSale	−10K sh	$62.43	−$624K	130,071
2023-10-01	MLTXMoonLake ImmunotherapeuticsC Conversion	Chief Scientific Officer	CConversion	+2.53M sh	—	—	3,027,483
2023-10-01	MLTXMoonLake ImmunotherapeuticsD Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−2.53M sh	—	—	0
2023-10-01	MLTXMoonLake ImmunotherapeuticsC Conversion	Chief Scientific Officer	CConversion	+42K sh	—	—	140,071
2023-10-01	MLTXMoonLake ImmunotherapeuticsD Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−42K sh	—	—	196,316
2023-10-01	MLTXMoonLake Immunotherapeutics · Common shares, par value CHF 0.10 per share, of MoonLake AGC Conversion	Chief Scientific Officer	CConversion	−75.1K sh	—	—	0
2023-10-01	MLTXMoonLake Immunotherapeutics · Common shares, par value CHF 0.10 per share, of MoonLake AGC Conversion	Chief Scientific Officer	CConversion	−1,248 sh	—	—	5,836
2023-04-05	MLTXMoonLake ImmunotherapeuticsC Conversion	Chief Scientific Officer	CConversion	+500K sh	—	—	500,006
2023-04-05	MLTXMoonLake ImmunotherapeuticsD Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−500K sh	—	—	2,527,477
2023-04-05	MLTXMoonLake ImmunotherapeuticsC Conversion	Chief Scientific Officer	CConversion	+98.1K sh	—	—	98,090
2023-04-05	MLTXMoonLake ImmunotherapeuticsD Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−98.1K sh	—	—	238,297
2023-04-05	MLTXMoonLake Immunotherapeutics · Common shares, par value CHF 0.10 per share, of MoonLake AGC Conversion	Chief Scientific Officer	CConversion	−14.9K sh	—	—	75,136
2023-04-05	MLTXMoonLake Immunotherapeutics · Common shares, par value CHF 0.10 per share, of MoonLake AGC Conversion	Chief Scientific Officer	CConversion	−2,916 sh	—	—	7,084

Recent filings

Accepted (ET)
Jul 294
Reich Kristian0001213900-26-082804
SEC(opens sec.gov)
Jul 234
Reich Kristian0001213900-26-080869
SEC(opens sec.gov)
Jul 214
Reich Kristian0001213900-26-080133
SEC(opens sec.gov)
Jul 204
Reich Kristian0001213900-26-079376
SEC(opens sec.gov)
Jun 174
Reich Kristian0001213900-26-069753
SEC(opens sec.gov)
Jan 94
Reich Kristian0001213900-26-002905
SEC(opens sec.gov)
Dec 224
Reich Kristian0001213900-25-124516
SEC(opens sec.gov)
Dec 104
Reich Kristian0001213900-25-120105
SEC(opens sec.gov)
Sep 44
Reich Kristian0001213900-25-084492
SEC(opens sec.gov)
Mar 34
Reich Kristian0001213900-25-019673
SEC(opens sec.gov)
Jan 224
Reich Kristian0001213900-25-005686
SEC(opens sec.gov)

Companies

MoonLake ImmunotherapeuticsChief Scientific OfficerMLTX

Address

C/O MOONLAKE IMMUNOTHERAPEUTICS DORFSTRASSE 29

ZUG, 6300